As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...
Steel Horse Rides on MSN
BYD surpasses Tesla to claim global EV sales crown in 2025
The turning point in 2025 was not a single quarter but the cumulative effect of BYD’s relentless volume growth against a ...
Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback